Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SGS announced the company will implement the Veeva Vault CTMS across its network of clinical operations sites for the management of its global clinical study services.
read more
SGS announced that it has successfully implemented Oracle Argus database in response to changing pharmacovigilance requirements for processing solicited and unsolicited adverse events.
read more
Thursday, February 23, 2017
SGS has announced the launch of Simulo®, an in-silico modeling and simulation platform which facilitates complex clinical trial simulation to predict the expected results of prospective trials, while optimizing study design to increase the ...
read more
Nikki Schopp, Team Leader, Analytical Laboratory Services, at leading pharmaceutical analytical and bioanalytical contract solutions provider, SGS Life Science Services, is to present at the forthcoming Interphex trade show, being held from 18th to ...
read more
Wednesday, August 09, 2017
SGS is expanding its facility in Lincolnshire, in the northern suburbs of Chicago, Illinois.
read more
Friday, February 15, 2013
SGS expands its Clinical Pharmacology Unit in Antwerp, Belgium with a Viral Challenge Testing facility including a 12-bed, Biosafety Level 2-Q compliant, quarantine facility.
read more
Wednesday, January 30, 2019
SGS has invested £7.6 million in its facility in Glasgow to expand the capabilities and capacity for testing cell banks and routine bulk harvest for vaccines, gene and cell therapies, and monoclonal antibodies.
read more
SGS announced it has expanded storage capacity at its laboratory in Mississauga, Canada.
read more
SGS has announced that it has invested in multiple highly sensitive and selective LC-MS/MS instruments at its Poitiers, France laboratory, for the quantification of proteins and peptide therapeutics.
read more
SGS announced that it has significantly increased its capabilities to undertake extractables and leachables (E&L) testing at its Shanghai, China, laboratory. Its investment includes the installation of multiple analytical instruments, including an ...
read more
Wednesday, February 15, 2017
SGS is expanding its elemental analysis testing capabilities at its Villeneuve-la-Garenne, France laboratory. The site has invested in a new inductively coupled plasma mass spectrometry (ICP-MS) system, in a move to address the updated ICH Q3D ...
read more
Tuesday, November 13, 2018
SGS has expanded elemental analysis testing capabilities at its Chennai, India laboratory.
read more
SGS announced that it has acquired CMIC, INC., a specialized provider of bioanalytical testing services based in Chicago, Illinois.
read more
Friday, September 04, 2020
SGS has announced the enrollment of the first patient into a new clinical trial designed to examine the safety, tolerability, and efficacy of a potential drug candidate for people suffering with COVID-19 related respiratory failure.
read more
Wednesday, January 11, 2017
SGS has announced the forthcoming availability of a new strain of influenza virus for use as a challenge agent in clinical trials. The synthetic virus may be used to test the efficacy of both novel influenza drugs and vaccines in healthy volunteers.
read more